Histopathology results of vaccination sites collected from New Zealand white rabbits vaccinated with a lanolin-based Rabisin® vaccine
Year: 2026
Type: article
Abstract: This study aimed to assess whether a slow-release water in-oil emulsion rabies vaccine could potentially provide a safe and effective method to improve canine rabies control in future. We evaluated the safety and efficacy of a single dose of a lanolin-based adjuvant combined with a commercially available rabies vaccine used in canines (Rabisin®), compared to two doses of Rabisin® in 16 New Zealand white rabbits. Histopathology evaluation of the injection sites revealed only mild microscopic signs of inflammation, no abscessation or granuloma formation in either the lanolin or Rabisin® groups. Six of the eight samples collected from the Rabisin® group demonstrated a mild inflammatory infiltrate composed predominantly of eosinophils with fewer lymphocytes and scant plasma cells, whereas the remaining two samples showed minimal to no inflammatory changes. The biopsy sample collected on day 89 of the study from a female in the Rabisin® group was found to be within normal limits (no microscopic lesions), while one sample (from male number 21) had a single focus of locally extensive fibrous connective tissue with scant eosinophils and a few lymphocytes and plasma cells within the superficial dermis. The lanolin group had three of the eight samples with a microscopic appearance similar to the majority of the Rabisin® group, while two of the eight samples showed minimal to no inflammatory changes and two other samples showed only scattered, scant eosinophils within the superficial dermis. One of the eight samples collected from the lanolin group was similar to the findings of six of the eight samples collected from the Rabisin® group but had comparatively fewer lymphocytes and plasma cells. No residual mineral oil droplets were found in the lanolin group samples.
Source: University of Pretoria
Author: Leandra Wiid
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7234561520
